BRPI0813271A2 - Síntese regiosseletiva catalisada por cobre de benzimidazóis e azabenzimidazóis - Google Patents
Síntese regiosseletiva catalisada por cobre de benzimidazóis e azabenzimidazóisInfo
- Publication number
- BRPI0813271A2 BRPI0813271A2 BRPI0813271-2A2A BRPI0813271A BRPI0813271A2 BR PI0813271 A2 BRPI0813271 A2 BR PI0813271A2 BR PI0813271 A BRPI0813271 A BR PI0813271A BR PI0813271 A2 BRPI0813271 A2 BR PI0813271A2
- Authority
- BR
- Brazil
- Prior art keywords
- synthesis
- regososlective
- benzymidazous
- azabenzimidazous
- catalized
- Prior art date
Links
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 229910052802 copper Inorganic materials 0.000 title abstract 2
- 239000010949 copper Substances 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- -1 N-substituted benzimidazoles Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07290800 | 2007-06-26 | ||
| PCT/EP2008/004639 WO2009000413A1 (en) | 2007-06-26 | 2008-06-11 | A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0813271A2 true BRPI0813271A2 (pt) | 2014-12-30 |
Family
ID=38646504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0813271-2A2A BRPI0813271A2 (pt) | 2007-06-26 | 2008-06-11 | Síntese regiosseletiva catalisada por cobre de benzimidazóis e azabenzimidazóis |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8735586B2 (enExample) |
| EP (1) | EP2173721B1 (enExample) |
| JP (1) | JP5492770B2 (enExample) |
| KR (1) | KR20100023907A (enExample) |
| CN (1) | CN101687815A (enExample) |
| AT (1) | ATE539063T1 (enExample) |
| AU (1) | AU2008267444A1 (enExample) |
| BR (1) | BRPI0813271A2 (enExample) |
| CA (1) | CA2691857A1 (enExample) |
| IL (1) | IL202823A0 (enExample) |
| MX (1) | MX2009013753A (enExample) |
| WO (1) | WO2009000413A1 (enExample) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8299248B2 (en) | 2006-08-02 | 2012-10-30 | Cytokinetics, Incorporated | Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use |
| JP5774602B2 (ja) | 2009-12-30 | 2015-09-09 | アークル インコーポレイテッド | 置換されたイミダゾピリジニル−アミノピリジン化合物 |
| KR101477156B1 (ko) * | 2010-08-25 | 2014-12-29 | (주)네오팜 | 신규한 헤테로고리 화합물 및 이를 이용한 염증성 질환 치료용 조성물 |
| PE20140192A1 (es) | 2010-10-06 | 2014-02-24 | Glaxosmithkline Llc | Derivados de bencimidazol como inhibidores de cinasa pi3 |
| ES2571741T3 (es) | 2011-03-31 | 2016-05-26 | Bayer Ip Gmbh | Bencimidazoles sustituidos como inhibidores de Mps-1 quinasa |
| AU2012272937B2 (en) | 2011-06-24 | 2016-09-29 | Arqule, Inc | Substituted imidazopyridinyl-aminopyridine compounds |
| US8815854B2 (en) | 2011-06-24 | 2014-08-26 | Arqule, Inc. | Substituted imidazopyridinyl compounds |
| JPWO2013191188A1 (ja) * | 2012-06-22 | 2016-05-26 | 住友化学株式会社 | 縮合複素環化合物 |
| CN102924460B (zh) * | 2012-11-05 | 2015-12-16 | 南京师范大学 | 一种4H-吡咯并[1,2-a]苯并咪唑衍生物及其合成方法和应用 |
| WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
| WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
| AU2013365926B9 (en) | 2012-12-21 | 2019-01-17 | Zenith Epigenetics Ltd. | Novel heterocyclic compounds as bromodomain inhibitors |
| CN103130811B (zh) * | 2013-03-11 | 2015-02-25 | 河南师范大学 | 一种5,6-二氢吡唑并[1,5-c]喹唑啉类化合物的合成方法 |
| JP2016512219A (ja) | 2013-03-15 | 2016-04-25 | シンジェンタ パーティシペーションズ アーゲー | 殺菌活性のあるイミダゾピリジン誘導体 |
| WO2014151367A1 (en) | 2013-03-15 | 2014-09-25 | Janssen Pharmaceutica Nv | 1,2,5-substituted benzimidazoles as flap modulators |
| US9695149B2 (en) | 2013-03-15 | 2017-07-04 | Janssen Pharmaceutica Nv | 1,2,6-substituted benzimidazoles as flap modulators |
| ES2661437T3 (es) | 2013-06-21 | 2018-04-02 | Zenith Epigenetics Corp. | Nuevos compuestos bicíclicos sustituidos como inhibidores de bromodominio |
| SI3010503T1 (sl) | 2013-06-21 | 2020-07-31 | Zenith Epigenetics Ltd. | Novi biciklični inhibitorji bromodomene |
| CN105593224B (zh) | 2013-07-31 | 2021-05-25 | 恒元生物医药科技(苏州)有限公司 | 作为溴结构域抑制剂的新型喹唑啉酮类化合物 |
| MX2016006657A (es) | 2013-11-22 | 2016-10-12 | CL BioSciences LLC | Antagonistas de gastrina (por ejemplo, yf476, netazepido) para el tratamiento y prevencion de osteoporosis. |
| CN103965136B (zh) * | 2014-05-07 | 2016-09-07 | 苏州波菲特新材料科技有限公司 | 一种制备n-甲基噻唑啉-2-酮类化合物的方法 |
| EP3227280B1 (en) | 2014-12-01 | 2019-04-24 | Zenith Epigenetics Ltd. | Substituted pyridines as bromodomain inhibitors |
| US10710992B2 (en) | 2014-12-01 | 2020-07-14 | Zenith Epigenetics Ltd. | Substituted pyridinones as bromodomain inhibitors |
| US10292968B2 (en) | 2014-12-11 | 2019-05-21 | Zenith Epigenetics Ltd. | Substituted heterocycles as bromodomain inhibitors |
| CA2966450A1 (en) | 2014-12-17 | 2016-06-23 | Olesya KHARENKO | Inhibitors of bromodomains |
| JP6964343B2 (ja) | 2015-11-20 | 2021-11-10 | フォーマ セラピューティクス，インコーポレイテッド | ユビキチン特異的プロテアーゼ１阻害剤としてのプリノン |
| CN106519250A (zh) * | 2016-09-29 | 2017-03-22 | 辽宁石油化工大学 | 含氮小分子有机配体调节荧光发射性质的一维链状铜配位聚合物的制备方法 |
| GB201617630D0 (en) | 2016-10-18 | 2016-11-30 | Cellcentric Ltd | Pharmaceutical compounds |
| WO2018125799A2 (en) | 2016-12-29 | 2018-07-05 | Viamet Pharmaceuticals (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
| DK3562487T3 (da) | 2016-12-29 | 2024-01-02 | Ji Xing Pharmaceuticals Hong Kong Ltd | Metalloenzyminhibitorforbindelser |
| EP3615529B1 (en) | 2017-04-26 | 2024-06-05 | Basilea Pharmaceutica International AG, Allschwil | Processes for the preparation of furazanobenzimidazoles and crystalline forms thereof |
| WO2019014352A1 (en) | 2017-07-11 | 2019-01-17 | Vertex Pharmaceuticals Incorporated | CARBOXAMIDES AS INHIBITORS OF SODIUM CHANNELS |
| WO2019055877A1 (en) | 2017-09-15 | 2019-03-21 | Forma Therapeutics, Inc. | TETRAHYDROIMIDAZO QUINOLINE COMPOSITIONS AS INHIBITORS OF CBP / P300 |
| GB201800688D0 (en) | 2018-01-16 | 2018-02-28 | Redag Crop Prot Ltd | Agricultural chemicals |
| GB201806320D0 (en) | 2018-04-18 | 2018-05-30 | Cellcentric Ltd | Process |
| AU2019295790B2 (en) | 2018-06-29 | 2023-07-13 | Forma Therapeutics, Inc. | Inhibiting creb binding protein (CBP) |
| CN120365272A (zh) | 2018-10-05 | 2025-07-25 | 安娜普尔纳生物股份有限公司 | 用于治疗与apj受体活性有关的疾病的化合物和组合物 |
| CN114269383A (zh) | 2019-01-08 | 2022-04-01 | 菲斯生物制药公司 | 金属酶抑制剂化合物 |
| WO2020146682A1 (en) | 2019-01-10 | 2020-07-16 | Vertex Pharmaceuticals Incorporated | Carboxamides as modulators of sodium channels |
| US12440481B2 (en) | 2019-01-10 | 2025-10-14 | Vertex Pharmaceuticals Incorporated | Esters and carbamates as modulators of sodium channels |
| WO2020190791A1 (en) | 2019-03-15 | 2020-09-24 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (creb) |
| CN110982806B (zh) * | 2019-08-30 | 2022-09-02 | 浙江工业大学 | 一种蛋白质芳基衍生物及其制备方法 |
| PH12022551379A1 (en) | 2019-12-06 | 2023-05-03 | Vertex Pharma | Substituted tetrahydrofurans as modulators of sodium channels |
| CN111206260B (zh) * | 2020-02-12 | 2022-03-22 | 齐鲁工业大学 | 一种吡啶并[1,2-a]苯并咪唑类化合物的电化学合成方法 |
| US11795168B2 (en) | 2020-09-23 | 2023-10-24 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP) |
| US11801243B2 (en) | 2020-09-23 | 2023-10-31 | Forma Therapeutics, Inc. | Bromodomain inhibitors for androgen receptor-driven cancers |
| DK4347031T3 (da) | 2021-06-04 | 2025-12-01 | Vertex Pharma | N-(hydroxyalkyl-(hetero)aryl)-tetrahydrofuran-carboxamider som modulatorer af natriumkanaler |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR122020004679B1 (pt) * | 2005-12-19 | 2021-09-21 | Raqualia Pharma Inc | Composição farmacêutica |
| BRPI0720131A2 (pt) * | 2006-12-06 | 2014-02-04 | Boehringer Ingelheim Int | Glicocorticoides miméticos, métodos para fazê-los, composições farmacêuticas e usos dos mesmos. |
-
2008
- 2008-06-11 JP JP2010513710A patent/JP5492770B2/ja not_active Expired - Fee Related
- 2008-06-11 AT AT08759158T patent/ATE539063T1/de active
- 2008-06-11 MX MX2009013753A patent/MX2009013753A/es active IP Right Grant
- 2008-06-11 BR BRPI0813271-2A2A patent/BRPI0813271A2/pt not_active IP Right Cessation
- 2008-06-11 CA CA002691857A patent/CA2691857A1/en not_active Abandoned
- 2008-06-11 EP EP08759158A patent/EP2173721B1/en not_active Not-in-force
- 2008-06-11 AU AU2008267444A patent/AU2008267444A1/en not_active Abandoned
- 2008-06-11 CN CN200880021896A patent/CN101687815A/zh active Pending
- 2008-06-11 WO PCT/EP2008/004639 patent/WO2009000413A1/en not_active Ceased
- 2008-06-11 KR KR1020097027120A patent/KR20100023907A/ko not_active Withdrawn
-
2009
- 2009-12-17 IL IL202823A patent/IL202823A0/en unknown
- 2009-12-22 US US12/644,401 patent/US8735586B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008267444A1 (en) | 2008-12-31 |
| EP2173721A1 (en) | 2010-04-14 |
| KR20100023907A (ko) | 2010-03-04 |
| IL202823A0 (en) | 2010-06-30 |
| EP2173721B1 (en) | 2011-12-28 |
| CN101687815A (zh) | 2010-03-31 |
| JP2010531313A (ja) | 2010-09-24 |
| ATE539063T1 (de) | 2012-01-15 |
| US8735586B2 (en) | 2014-05-27 |
| JP5492770B2 (ja) | 2014-05-14 |
| CA2691857A1 (en) | 2008-12-31 |
| US20100261909A1 (en) | 2010-10-14 |
| WO2009000413A1 (en) | 2008-12-31 |
| MX2009013753A (es) | 2010-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0813271A2 (pt) | Síntese regiosseletiva catalisada por cobre de benzimidazóis e azabenzimidazóis | |
| BRPI0813273A2 (pt) | Síntese catalisada por metal regiosseletivo de benzimidazóis e azabenzimidazóis anelados | |
| IL196431A0 (en) | A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles | |
| BRPI0813870A2 (pt) | Síntese catalisada por metal de transição de 2h-indazóis. | |
| MX2010009416A (es) | Compuestos heterociclicos como inhibidores de cxcr2. | |
| SI2134691T1 (sl) | Derivati kvinolina kot PARP in TANK inhibitorji | |
| EA201070238A1 (ru) | Соединения пиримидина | |
| EA201170154A1 (ru) | Производные пиридинопиридинонов, способ их получения и применение в терапии | |
| MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
| WO2008063781A3 (en) | Chemical compounds as cannabinoid receptor ligands | |
| EA201171211A1 (ru) | Производные оксадиазола | |
| NI200900151A (es) | Nuevo procedimiento de síntesis de la agomelatina. | |
| MX2012006805A (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa. | |
| EA201101099A1 (ru) | Гербициды, полученные из циклопентадиона | |
| NI200900153A (es) | Nuevo procedimiento de síntesis de la agomelatina. | |
| MX2012006696A (es) | Derivados de 3, 4, 4a, 10b-tetrahidro-1h-tiopirano-[4, 3-c]-isoqunolina. | |
| EA201070779A1 (ru) | Триазолсодержащие производные оксадиазола | |
| UA94837C2 (ru) | Способ синтеза (7-метокси-1-нафтил)ацетонитрила и применение в синтезе агомелатина | |
| MX2010004498A (es) | Derivados de ciclohexenoamida y su uso como antagonistas de trpv1. | |
| TN2011000355A1 (en) | Novel microbiocides | |
| BRPI0812829A2 (pt) | Processo para o acoplamento catalisado por paládio de alcinas terminais com tosilatos de arila | |
| NL1034604A1 (nl) | Verwijdering van waterstofcyanide uit synthesegas. | |
| NI200900152A (es) | Nuevo procedimiento de síntesis de la agomelatina | |
| UA85701C2 (ru) | Способ получения ингибиторов триптазы | |
| EA200801549A1 (ru) | Новые производные фенантридина в качестве антагонистов брадикинина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |